01 1Zydus Lifesciences
01 1LETERMOVIR
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-09-29
Pay. Date : 2021-09-17
DMF Number : 36024
Submission : 2021-06-19
Status : Active
Type : II
20
Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LETERMOVIR, with a corresponding US DMF Number 36024.
Remarkably, this DMF maintains an Active status since its submission on June 19, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 29, 2021, and payment made on September 17, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
